Ignite Creation Date:
2026-03-26 @ 3:20 PM
Ignite Modification Date:
2026-04-01 @ 2:40 AM
Study NCT ID:
NCT07485920
Status:
NOT_YET_RECRUITING
Last Update Posted:
2026-03-20
First Post:
2026-03-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Prospective, Multicenter Exploratory Clinical Study on Consolidation Therapy With Tislelizumab Combined With Nintedanib for Limited-stage Small Cell Lung Cancer
Sponsor:
The Affiliated Hospital of Qingdao University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2026-05-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2028-12-10
Primary Completion Date Type:
ESTIMATED
Completion Date:
2030-01-31
Completion Date Type:
ESTIMATED
First Submit Date:
2026-03-17
First Submit QC Date:
None
Study First Post Date:
2026-03-20
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2026-03-17
Last Update Post Date:
2026-03-20
Last Update Post Date Type:
ACTUAL